NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.

Federal judge blocks Trump’s second attempt at imposing $100,000 fee for H1-B visas

Judge Haywood Gilliam, of the U.S. District Court for the Northern District of California, blocked the Trump administration’s second attempt to require a $100,000 fee for H1-B visas, which allows foreign nationals in “specialty occupations” to live and work in the U.S. The fee was previously $5,000 to $10,000.

October 02, 2026

Vol.52 No.36

By Sara Willa Ernst

Podcast The Directors

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declining public trust in science?

September 25, 2026

Vol.52 No.35

By Claire Marie Porter and Paul Goldberg

Cancer Policy

NCI launches AI tool to help match patients to clinical trials

NCI Director Anthony Letai announced the development of TrialMatch, an AI tool that helps oncologists identify clinical trials for their patients.

September 25, 2026

Vol.52 No.35

By Sara Willa Ernst

Funding Opportunities

Cancer Grand Challenges, through the Torrey Coast Foundation and Cancer Research UK, commits up to $34M to gastroesophageal cancer research

Cancer Grand Challenges has launched two new targeted challenges focused on gastroesophageal cancer, with awards of up to $34 million available through support from the Torrey Coast Foundation and Cancer Research UK.

September 25, 2026

Vol.52 No.35

Clinical Roundup

COA survey finds high bispecific therapy adoption among community oncology practices

The Community Oncology Alliance announced results from a national survey examining how independent community oncology practices deliver bispecific therapies on Sept. 22.

September 25, 2026

Vol.52 No.35

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

YOU MAY BE INTERESTED IN

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

Federal judge blocks Trump’s second attempt at imposing $100,000 fee for H1-B visas

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

NCI launches AI tool to help match patients to clinical trials

Cancer Grand Challenges, through the Torrey Coast Foundation and Cancer Research UK, commits up to $34M to gastroesophageal cancer research

COA survey finds high bispecific therapy adoption among community oncology practices

Renew today!

Subscriber content

Never miss an issue!

Login

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

YOU MAY BE INTERESTED IN

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

Federal judge blocks Trump’s second attempt at imposing $100,000 fee for H1-B visas

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want itLucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

NCI launches AI tool to help match patients to clinical trials

Cancer Grand Challenges, through the Torrey Coast Foundation and Cancer Research UK, commits up to $34M to gastroesophageal cancer research

COA survey finds high bispecific therapy adoption among community oncology practices

Never miss an issue!

Login

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish